DiaMonTech: First-time product presentation of the 'D-Base' at the world-wide largest medical technology trade fair COMPAMED/MEDICA 2019

Berlin, 19 November 2019

The DiaMonTech product 'D-Base', a device for the non-invasive blood glucose measurement, is exhibited for the first time at a trade fair. The partner company seleon GmbH, a leading international medical technology service provider, will present the measuring device at its stand at the COMPAMED/MEDICA 2019 medical technology trade fair. Visitors will have the opportunity to test the device in hall 8b at stand G05 and can thus determine their blood glucose level precisely and completely painlessly within seconds.

"We are pleased to be able to exhibit the 'D-Base' at our stand. It is one of the major innovations at this year's COMPAMED/MEDICA 2019. As a partner of DiaMonTech, we have contributed to the development of this great technology", says Harald Genger, managing director of seleon GmbH. "We perceive this technology as a milestone for millions of diabetics in Germany. Visitors to our stand can familiarise themselves with the new measuring technology."

The 'D-Base' allows non-invasive blood glucose measurement using a laser-based technology and is optimized for use in professional environments (e.g. diabetes centers). The measuring instrument received the CE-certification in March this year. The handling is simple: the user places his finger on a sensor field for a few seconds and the blood glucose level is shown on a display. The blood sugar can thus be measured precisely and painlessly without a drop of blood. The measurement can be made as often as desired without consumables (test strips). The need to prick several times a day is therefore completely omitted.

"The successful use of the 'D-Base' in practice is based on more than 20 years of intensive research and development work. We are working hard to make this technology available to as many diabetes patients as possible as quickly as possible, thereby making their lives easier. For this purpose, we are developing the smaller 'D-Pocket' in the size of a smartphone. We intend to launch this product on the market at the end of next year. It could thus be a constant 'companion' for diabetes patients", says Thorsten Lubinski, Co-founder and CEO of DiaMonTech AG.

About seleon
seleon GmbH has been developing and producing complex equipment for customers in the medical technology field since 1998, growing into a leading medical technology service provider. We develop individual solutions in partnership with our customers around the world, quickly leading to success. With our team of experienced physicists, engineers, computer scientists, process engineers and consultants, every one of our projects reaffirms our ambition to find innovative solutions and help our customers succeed in the market.

More information about seleon can be found at https://www.seleon.de.

About DiaMonTech

Founded in Berlin, Germany, in 2015, DiaMonTech is a medical technology company committed to improving health outcomes for people with diabetes and empowering them to take control of their lifelong health. Its pioneered and patented non-invasive “no prick” photothermal detection technology is fast and painless and doesn’t require needles or test strips. An industry first, DiaMonTech monitors the actual glucose molecules in skin, providing users with a more comprehensive and accurate reading comparable to invasive commercial devices. DiaMonTech achieved 99.1% accuracy in a test study with 100 people studied, received the CE mark as a medical device in April 2019 and is currently under FDA review. To support its mission, DiaMonTech is led by a world-class team of scientists, researchers and healthcare experts. 

More information about DiaMonTech can be found at www.diamontech.de.

Press contact
Markus Teuber
E-mail: hello@diamontech.de

The future begins now!

Stay tuned and get updates.

We are working hard in our lab day and night but it takes some time to develop a new medical device. Subscribe to our newsletter to get the latest news.

Notify me
Press
news@diamontech.de
INQUIRIES
hello@diamontech.de
Investor relations
ir@diamontech.de